Choice of an oral β-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 3, 1997, Pages 255-257

  Goldstein, Fred W ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE;

ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG CHOICE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PHARMACODYNAMICS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030740387     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709019038     Document Type: Article

References (19)

1. Baquero F. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Micro Drug Resist 1: 115-120, 1995.
2. Péan Y, Goldstein FW, Guerrier ML and the French Study Group. Highlights of the French Surveillance Project. Diag Microb Infect Dis 25: 191-194, 1996.
3. Geslin P. Bêta-lactamines et pneumocoques multi-résistants isolés en France (1984-1994). Méd et Hyg 53: 2111-2118, 1995.
4. Goldstein FW, Acar JF and The Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992 93 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 38: 71-84, 1996.
5. McCracker GH Jr. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis 14: 424-428, 1995.
6. Chesney PJ. The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. Am J Dis Child 146: 912-916, 1992.
7. Munoz R, Musser JM, Crain M, Briles DE, Marton A, Parkinson AJ, Sorensen U, Tomasz A. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing and multilocus enzyme analysis. Clin Infect Dis 15: 112-118, 1992.
8. Laible G, Hakenbeck R. Penicillin-binding proteins in β-lactam resistant laboratory mutants of Streptococcus pneumoniae. Molec Microbiol 1: 355-363, 1987.
9. Coffey TJ, Daniels M, McDougal LK, Dowson CG, Tenover FC, Spratt BG. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 39: 1306-1313, 1995.
10. Goldstein FW. Résistance des pneumocoques. Rev Prat 8: 1068-1073, 1994.
11. Sifaoui F, Kitzis MD, Gutmann L. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrob Agents Chemother 40: 152-156, 1996.
12. Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig WA. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 158: 831-847.
13. Frimodt-Möller N, Bentzon MW, Thomsen VF. Experimental infection with Streptococcus pneumoniae in Mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. Journal? 154: 511-517, 1986.
14. Drusano GL. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother 32: 289-297, 1988.
15. Drusano GL, Goldstein FW. Relevance of the Alexander Project: pharmacodynamic considerations. J Antimicrob Chemother 38: 141-154, 1996.
16. Cohen R, de la Rocque F, Boucherat M, Doit C, Bingen E, Geslin P. Treatment failure in otitis media: an analysis. J Chemother 6: 17-22, 1994.
17. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 39: 271-272, 1995.
18. Ottolini MG, Ascher DP, Cieslak TJ, Modica-Lucero S. Pneumococcal bacteremia during oral treatment with cefixime for otitis media. Pediatr Infect Dis J 10: 467-468, 1991.
19. Dhoycn N, Goldstein FW, Kitzis MD, Acar JF, Gutmann J. Spontaneous resistant mutants of Streptococcus pneumoniae isolated after selection on cefotaxime and celixime. Prague: Poster 77, 6th ICID, 1994.